Translate page

Dr Syed Owais Ali, MD
(Rawalpindi, Pakistan)

John Goldman Conference Dr Ali Kopie'I’m very lucky to have the opportunity to come to this conference. I have learned a lot by listening to the presentations and by interacting with people from other countries and from other universities and I now have the full picture in my mind. 

Back home in my country I will be sharing everything that I have seen and learned here and this will help us to treat our CML patients in the right way and to better serve our patients. (Dr Owais Ali, Pakistan)

034 ESH CML 2017 Kopie

Syed Owais Ali’s attendance at the John Goldman Conference on CML in Estoril in 2017 was supported by the iCMLf Goldman Fund. At a ceremony shortly after the opening of the conference, he received a certificate from the iCMLf chairman, Professor Tim Hughes.

Dr Marica Pavcovic, MD, PhD 
(Skopje, Macedonia)

John Goldman Conference Nicola Marica Kopie‘Coming to this conference complemented my practical learnings during my preceptorship at the Hammersmith Hospital very well.

It’s great to have a conference with a focus on CML only. I especially like the interactive poster walks at this meeting where the audience asks so many questions’
(Dr Pavcovic, Macedonia)

032 ESH CML 2017 Kopie

Marica Pavcovic’s attendance at the John Goldman Conference on CML in Estoril in 2017 was supported by the iCMLf Goldman Fund. At a ceremony shortly after the opening of the conference, she received a certificate from the iCMLf chairman, Professor Tim Hughes.

Dr Uzma Zaidi 
(Karachi, Pakistan)

Uzma Zaidi

‘I thank iCMLf for providing me the opportunity to participate in the 18th John Goldman Conference. I got a chance to listen to international experts, to see what approaches they are following and how they are managing their patients. This meeting has greatly enhanced my knowledge on CML and given me so many new ideas to better help my patients in home town, both from the diagnostic and the management point of view’.
(Dr Zaidi, Pakistan) 

Uzma Zaidi was supported by the iCMLf Goldman Fund to attend the John Goldman Conference on CML in Houston in 2016. She also undertook a 4-week clinical preceptorship at the MD Anderson Cancer Center in Houston directly after her attendance at the meeting. 

‘The main issue in Pakistan is to get access to regular monitoring for my patients. 
I am hoping to learn some diagnostic techniques during the preceptorship and to improve my skills and knowledge in terms of diagnosis and biology of CML. This will help me to find solutions for my patients’. 
(Dr Zaidi in advance of her preceptorship)

Dr Adeagbo Babatunde, PhD

(Ile-Ife, Nigeria)

Dr Babatunde2'It was an honour for me to present my data at this well-known conference on CML and to discuss the results with the international CML community. It was also a great chance for me to network with people from around the world and a great experience for me to listen to some of the most renowned leaders in the field of CML during the scientific sessions at the meeting.' 
(Dr Babatunde, Nigeria)

Dr Babatunde was supported by the John Goldman Fund in 2015 to attend the John Goldman Conference on CML in Estoril. He presented his poster on ‘Pharmacokinetics on imatinib in Nigerians’ with CML during the interactive poster walks on the biology of CML.

You can read his full abstract here

Dr Kotlyarchuk, MD
(Lviv, Ukraine)

Dr Kotlyarchuk2'Thank you very much for your help and support which enabled my participation in the 17th John Goldman Conference. It was an unforgettable experience from many points of view: a great chance to spend 4 days of CML education from the top lecturers; meeting some very nice people; presenting our own data; obtaining ground for new ideas as to how and which way we should move in terms of improving CML management at home; participating in a Fun Run which was a new experience for me!' (Dr Kotlyarchuk, Ukraine)

Dr Kotlyarchuk was supported by the John Goldman Fund in 2015to attend the John Goldman Conference on CML in Estoril. He presented his poster on ‘Pregnancy in chronic myeloid leukemia – an analysis of 19 cases’ during the interactive clinical poster walks.

You can read his full abstract here